An Enhanced Retention Strategy to Prevent the Vertical Transmission of HIV in Uganda: A Budget Impact Analysis [0.03%]
乌干达防治母婴传播的强化保留方案：预算影响分析
Elly Nuwamanya,Benjamin C Johnson,Stephen Okoboi et al.
Elly Nuwamanya et al.
Background: Novel retention strategies have the potential to reduce vertical transmission of HIV and improve patient outcomes for women living with HIV (WLHIV) and their infants. We estimated the budget impact of the enha...
The Importance of a Methodological Manual for Economic Evaluations in Healthcare Decision-Making in Ecuador [0.03%]
厄瓜多尔卫生决策经济评估的方法手册的重要性
Ricardo Yajamín-Villamarín
Ricardo Yajamín-Villamarín
This article provides an overview of Ecuador's Methodological Manual for Economic Evaluations of Health Technologies, emphasizing its importance, key methodological aspects, and relevance within the country's health technology assessment (H...
Adjusting Health State Utility Values for Multiple Conditions: Real-World EQ-5D-3L Data Modeling in Brazil [0.03%]
基于巴西真实数据的EQ-5D-3L多状态健康状况效用值调整模型研究
Milene Rangel da Costa,Bráulio Dos Santos Júnior,Marisa da Silva Santos
Milene Rangel da Costa
Background and objective: Decision analytical models are typically included in health economic evaluations to represent clinical pathways and enable the estimation of clinical and economic outcomes of health technologies....
Exploratory Cost-Effectiveness of a Novel Bioprosthetic Valve for Surgical Aortic Valve Replacement in Spain [0.03%]
西班牙外科主动脉瓣置换新型生物瓣膜的探索性成本效益分析
María Ascaso,Daniel Pérez,Lourdes Montero et al.
María Ascaso et al.
Objectives: Limited information is available regarding the impact of valve choice for patients with aortic stenosis (AS) undergoing surgical aortic valve replacement (SAVR) in Spain. Herein, we aimed to explore the potent...
Cost-Effectiveness Analyses of Adolescent- and Young-Adult-Focused HIV Interventions Incorporating HIV Transmission: a Scoping Review of Modeling Methods and Proposed Guidance [0.03%]
纳入HIV传播的以青少年和年轻成年人为重点的HIV干预措施的成本效益分析：建模方法综述及建议指南
Wanyi Chen,Simeng Li,Carol Mita et al.
Wanyi Chen et al.
Background: Adolescents and young adults (AYA) are disproportionately affected by human immunodeficiency virus (HIV) globally, with high-burden population subgroups differing across regions. Cost-effectiveness modeling an...
Economic Evaluation of Patiromer in Patients with Concomitant Heart Failure and Chronic Kidney Disease in Italy [0.03%]
意大利伴发心力衰竭和慢性肾脏病患者的帕罗培素经济学评价
M Senni,E Paoletti,Ewa Stawowczyk et al.
M Senni et al.
Background: Hyperkalaemia (HK), in patients with heart failure (HF) with and without chronic kidney disease (CKD), is potentially life-threatening. Risk of HK is further heightened in those patients receiving renin-angiot...
Assessing the Value for Money of Enzyme Replacement Therapy in Gaucher Disease Types 1 and 3b: Can Expanded Coverage Be Justified? [0.03%]
关于戈谢病I型和3b型的酶替代疗法的价值评估：能否扩大用药范围？
Waranya Rattanavipapong,Thunyarat Anothaisintawee,Wanrudee Isaranuwatchai et al.
Waranya Rattanavipapong et al.
Background and objectives: The Health Intervention and Technology Assessment Program was commissioned to conduct a cost-utility and budget impact analysis of enzyme replacement therapy (ERT) for Gaucher disease types 1 an...
Using Generative Artificial Intelligence in Health Economics and Outcomes Research: A Primer on Techniques and Breakthroughs [0.03%]
用于健康经济与结果研究的生成式人工智能：技术与突破简介
Tim Reason,Sven Klijn,Will Rawlinson et al.
Tim Reason et al.
The emergence of generative artificial intelligence (GenAI) offers the potential to enhance health economics and outcomes research (HEOR) by streamlining traditionally time-consuming and labour-intensive tasks, such as literature reviews, d...
Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in High-Risk Older Adults in Japan [0.03%]
莫努匹拉韦治疗日本高危老年新冠门诊患者的成本效益分析：与最优支持护理相比
Hardik Goswami,Atsushi Tajima,Taizo Matsuki et al.
Hardik Goswami et al.
Objectives: This analysis aimed to evaluate the cost effectiveness of molnupiravir versus best supportive care for the treatment of older adult patients (aged ≥ 65 years) in Japan with mild to moderate COVID-19 who are a...
A Systematic Literature Review of the Economic and Healthcare Resource Utilization Burden of Relapsed/Refractory Follicular Lymphoma [0.03%]
复发/难治性滤泡淋巴瘤的经济和医疗资源利用负担的系统评价文献回顾
Bijal Shah,Mei Xue,Wesley Furnback et al.
Bijal Shah et al.
Objective: To quantify the economic or healthcare resource utilization (HCRU) burden and examine the value of interventions for relapsed or refractory (R/R) follicular lymphoma (FL). ...